The tweet was deleted by the author.
But we saved everything 🙂.
Arcturus Therapeutics announced it will attend the upcoming Leerink Partners 2026 Global Healthcare Conference.
The company aims to present its advancements in mRNA therapeutics and rare disease treatment at the event. The conference is considered a major gathering for leaders in the healthcare and biotech sectors. Details regarding presentation schedules and potential partnerships or business developments are expected to be disclosed at the conference.
The upcoming conference appearance builds on Arcturus Therapeutics’ recent momentum in mRNA innovation and business development—a trend underscored by the company’s latest financial reporting and pipeline progress. For a detailed examination of these developments, see the earlier analysis of Arcturus Therapeutics’ financial results and mRNA pipeline updates.